Industry

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology QuantiFERON-TB Gold Plus plays a critical role in fighting the spread of TB worldwide VENLO, The Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: … [Read more…]

Ansell Expands Portfolio to Include Kimtech, KleenGuard and RightCycle Brands in North America and Europe

MELBOURNE, Australia–(BUSINESS WIRE)–Ansell Limited (ASX: ANN), a global leader in protection solutions, announced today that its sales organisation will begin accepting Kimtech™ and KleenGuard™ orders and managing customer inquiries across North America and Europe. This marks the first significant commercial milestone following the strategic acquisition of Kimberly-Clark’s Personal Protective Equipment (KCPPE) business last year and … [Read more…]

BostonGene to Showcase Multi-Modal AI-Powered Platform at the 22nd Annual Meeting of the Japanese Society of Medical Oncology

Advancing Precision Oncology with AI-Driven Multiomics for Optimized Therapy Selection and Improved Patient Outcomes WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced its participation in the 22nd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2025) from March 6–8, 2025, in Kobe, Japan. This premier conference is … [Read more…]

Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies

– First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) – – Results were featured as late-breakers at the 2025 AAAAI Annual Meeting – – Xolair is the only U.S. FDA-approved medicine to reduce allergic reactions in children and adults with one or more food allergies – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of … [Read more…]

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need for surgery in patients with chronic rhinosinusitis with nasal polyps WAYPOINT data published in New England Journal of Medicine and highlighted as late-breaking oral presentation at AAAAI/WAO 2025 WILMINGTON, Del.–(BUSINESS WIRE)–Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s … [Read more…]

Prime Healthcare Completes Historic Acquisition of Ascension Hospitals and Care Sites in Illinois

ONTARIO, Calif.–(BUSINESS WIRE)–#InPrimeHealth–Prime Healthcare announced today that it has successfully completed the historic acquisition of eight Ascension Illinois hospitals, four senior living and post-acute care facilities, and physician practices, signaling a new era of service excellence and award-winning healthcare in the Greater Chicago area. After an extensive review process, the Illinois Health Facilities and Services … [Read more…]

DJ Spinderella Reunites with AHF for Florida AIDS Walk 20th Anniversary

Annual 5k and music festival prepares to celebrate two decades of raising millions of dollars for South Florida HIV/AIDS nonprofit, service organizations FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Legendary hip hop DJ and rapper DJ Spinderella, who rose to fame with the iconic rap group Salt-N-Pepa, will be joining AIDS Healthcare Foundation’s 20th year celebration of the Florida … [Read more…]

Viromed Medical AG reaches milestone for cooperation with multinational corporation

PINNEBERG, Germany–(BUSINESS WIRE)–Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) has reached a milestone in the extensive cooperation with a multinational corporation announced via ad hoc notification on 11 December 2024. The subject of the agreement now concluded is, in particular, the granting of a European license right in favour of Viromed Medical AG for the … [Read more…]

SmithRx Introduces Stelara Biosimilars to Its Autoimmune Program, Helping Clients Save a Projected $14.5M in Prescription Drug Costs

SmithRx is first PBM to meaningfully embrace biosimilars to drive savings for clients SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), today announced a major expansion to its Connect 360 Autoimmune Program, including the introduction of Stelara biosimilars to its offering, new low-cost Humira and Stelara biosimilars for pediatric members, and … [Read more…]

Wedgewood Appoints Jessica Knopp-Gwynne as Chief Revenue Officer to Drive Strategic Growth

SWEDESBORO, N.J.–(BUSINESS WIRE)–#BlueRabbit–Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Jessica Knopp-Gwynne as Chief Revenue Officer. Knopp-Gwynne brings extensive expertise in revenue growth, commercial strategy, and customer-centric innovation, reinforcing Wedgewood’s commitment to delivering value-driven solutions for veterinary professionals and animal owners. A Proven Leader in Growth and Strategy With … [Read more…]